Table 1 Clinicopathological characteristics
Parameters | All patients (n = 102) (n) | Percentage (%) |
|---|---|---|
Age (yr) | 51.71 ± 8.01 | |
≤ 52 | 49 | 48.0 |
> 52 | 53 | 52.0 |
Menopause | ||
Premenopause | 35 | 34.3 |
Postmenopause | 67 | 65.7 |
Family history of malignancy | ||
No | 84 | 82.4 |
Yes | 18 | 17.6 |
Tumor size | ||
<10cm | 33 | 32.3 |
≥10cm | 69 | 67.7 |
CA125 (u/ml) | ||
≤35 | 48 | 47.1 |
>35 | 54 | 52.9 |
Ascites positivity | ||
No | 87 | 85.3 |
Yes | 15 | 14.7 |
Endometriosis | ||
No | 33 | 32.4 |
Yes | 69 | 67.6 |
Surgical approach | ||
Laparotomy | 91 | 89.2 |
Laparoscopy | 11 | 10.8 |
FIGO | ||
IA | 46 | 45.0 |
IB | 0 | 0 |
IC | 43 | 42.2 |
IIA | 13 | 12.8 |
Chemotherapy cycle | ||
1-3 | 20 | 19.6 |
≥4 | 82 | 80.4 |